LONDON, June 28, 2024 /PRNewswire/ — Tetragon has released its Monthly Factsheet for May 2024. – Net Asset Value: $ 2,817m – Fully Diluted NAV Per Share: $31.49 – Share Price (TFG NA): $10.20 – Monthly NAV per share total return: 0.7% – Monthly Return on Equity: 1.2% – Most recent…
Month: June 2024
Le groupe NX signe un accord de partenariat stratégique avec Controlant d’Islande
– Mise en place d’un service de surveillance en temps réel pour le suivi de l’emplacement des cargaisons et un contrôle rigoureux de la température – TOKYO, 28 juin 2024 /PRNewswire/ — NIPPON EXPRESS HOLDINGS, INC. a signé un accord de partenariat stratégique avec Controlant, Inc. basé…
Le groupe NX signe un accord de partenariat stratégique avec Controlant d’Islande
– Mise en place d’un service de surveillance en temps réel pour le suivi de l’emplacement des cargaisons et un contrôle rigoureux de la température – TOKYO, 28 juin 2024 /PRNewswire/ — NIPPON EXPRESS HOLDINGS, INC. a signé un accord de partenariat stratégique avec Controlant, Inc. basé…
Hansa Biopharma: increase in number of shares and votes
LUND, Sweden, June 28, 2024 /PRNewswire/ — Hansa Biopharma AB, (“Hansa Biopharma” or the “Company”) (NASDAQ: HNSA) (STOCKHOLM: HNSA) today announced that Hansa’s registered share capital and number of shares and votes have increased through (i) the issue of 2,305,260 new ordinary shares…
Hansa Biopharma: increase in number of shares and votes
LUND, Sweden, June 28, 2024 /PRNewswire/ — Hansa Biopharma AB, (“Hansa Biopharma” or the “Company”) (NASDAQ: HNSA) (STOCKHOLM: HNSA) today announced that Hansa’s registered share capital and number of shares and votes have increased through (i) the issue of 2,305,260 new ordinary shares…
Hansa Biopharma: increase in number of shares and votes
LUND, Sweden, June 28, 2024 /PRNewswire/ — Hansa Biopharma AB, (“Hansa Biopharma” or the “Company”) (NASDAQ: HNSA) (STOCKHOLM: HNSA) today announced that Hansa’s registered share capital and number of shares and votes have increased through (i) the issue of 2,305,260 new ordinary shares…
Hansa Biopharma: increase in number of shares and votes
LUND, Sweden, June 28, 2024 /PRNewswire/ — Hansa Biopharma AB, (“Hansa Biopharma” or the “Company”) (NASDAQ: HNSA) (STOCKHOLM: HNSA) today announced that Hansa’s registered share capital and number of shares and votes have increased through (i) the issue of 2,305,260 new ordinary shares…
Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 /PRNewswire/ — Sirnaomics Ltd. (the “Company”, together with its subsidiaries, the “Group” or “Sirnaomics”; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi…
Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 /PRNewswire/ — Sirnaomics Ltd. (the “Company”, together with its subsidiaries, the “Group” or “Sirnaomics”; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi…
Ibanera and DMALINK Forge Strategic Partnership to Equip Tech Companies for Global Success
LONDON, June 28, 2024 /PRNewswire/ — DMALINK, a leading data-driven Electronic Communication Network (ECN) specializing in institutional foreign exchange (FX) trading, and Ibanera, a distinguished global financial infrastructure provider, today announced a strategic partnership to tackle…
